← Open Payments lookup

JAMESHA TUMBLIN: Open Payments

NPI 1083975742 · SMITHVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$455 in 22 payments from 9 companies in 2025. Trend: 2023 $642 · 2024 $550 · 2025 $455

Food & beverage: $435Education: $20
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation9$201
Calliditas Therapeutics US Inc.2$56
Bayer Healthcare Pharmaceuticals Inc.3$50
Aurinia Pharma U.S., Inc.2$44
AstraZeneca Pharmaceuticals LP2$28
Otsuka America Pharmaceutical, Inc.1$20
OPKO Pharmaceuticals, LLC1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
AKEBIA THERAPEUTICS INC1$17

Products named: Fabhalta, Vanrafia, TARPEYO, Kerendia, LUPKYNIS, JYNARQUE, RAYALDEE, JARDIANCE.

Industry payments across MS — which companies pay providers there.